GoodRx Holdings Inc.

07/24/2024 | Press release | Distributed by Public on 07/24/2024 16:27

Can’t Fill Your Zepbound Prescription? Here Are 5 Zepbound Alternatives to Consider

Key takeaways:

  • Zepbound (tirzepatide) is a once-weekly injection that's FDA approved for weight loss. Because of its growing popularity, there's a shortage of the medication and people may be looking for alternatives.

  • Injectable Zepbound alternatives include Wegovy (semaglutide) and Saxenda (liraglutide). These are the most similar weight-loss alternatives, but there are also shortages impacting them.

  • Oral Zepbound alternatives include Contrave (naltrexone / bupropion), Qsymia (phentermine / topiramate ER), and Xenical (orlistat). These medications are more readily available, but they may not provide as much weight loss as Zepbound.

Access savings to related medications

info_outlinedPromotional disclosure
HRAUN/E+ via Getty Images

Zepbound (tirzepatide) is one of several FDA-approved weight-loss medications. This once-weekly injection mimics the effects of two natural gut hormones: glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). Taking Zepbound has led to significant weight loss for many people.

Zepbound has been growing in popularity since its FDA approval. But because of this increase in demand, there's a shortage of the medication. This has many people looking at other options. But what's available for chronic weight management? Below, we'll review five Zepbound alternatives your prescriber may discuss with you.

1. Wegovy

Wegovy (semaglutide) is very similar to Zepbound. It's also a once-weekly injection that can provide significant weight loss. But Wegovy only acts like one gut hormone: GLP-1. Zepbound is currently the only FDA-approved weight-loss medication that acts like both GLP-1 and GIP.

EXPERT PICKS: WHAT TO READ NEXT
  • Compare options:Zepbound and Wegovy have a few notable differences. Read more about how they compare for weight loss.

  • How it works: Zepbound mimics the effects of two gut hormones, which helps promote weight loss. Read about how Zepbound works here.

  • Standard dosages: To limit side effects, it's recommended to start with a low Zepbound dose and gradually raise it. Read more about the typical Zepbound dosage schedule.

This difference in how each works means that Zepbound may provide greater weight loss than Wegovy for some people. An ongoing head-to-head clinical trial is looking to confirm whether this is true.

Wegovy has a few notable differences from Zepbound. Beyond weight loss, it's also approved to lower the risk of serious cardiovascular problems for adults considered to be overweight or obese and who also have heart disease. Zepbound's cardiovascular benefits are still being studied. If you also have heart disease, your prescriber may switch you to Wegovy for its added heart benefits. It may also be more likely to be covered by insurance for this reason.

Wegovy also has the advantage of being approved for adults and adolescents ages 12 and older. Zepbound is still being studied for use in children, so it's currently only approved for adults.

As with Zepbound, there's a shortage of Wegovy. So while this could be the most ideal Zepbound alternative for you, it may be difficult to find it at pharmacies.

2. Saxenda

Saxenda (liraglutide) is another weight-loss injection. It belongs to the same class as Wegovy and acts like the gut hormone GLP-1 in the body. But unlike Zepbound and Wegovy, you'll need to inject Saxenda once a day.

Similar to Zepbound, Saxenda doesn't have proven cardiovascular benefits. But Saxenda is approved for adolescents ages 12 and older. However, based on individual clinical trials, Zepbound may cause more weight loss than Saxenda.

People taking Zepbound for 72 weeks (16.5 months) in clinical trials lost an average of 15% to 20% of their starting body weight. People taking Saxenda for 56 weeks (almost 13 months) lost an average of 8% of their body weight. But keep in mind that these medications haven't been compared directly in a head-to-head clinical trial.

If you switch from Zepbound to Saxenda, be aware that their injection pens are different. Zepbound's pen comes with a needle already attached to it and is meant for a single use. You will discard the pen in a sharps container after you inject it. Saxenda's pen, however, is meant for multiple uses. So before each Saxenda dose, you will attach a fresh pen needle.

As with Zepbound and Wegovy, Saxenda is also in short supply. So it could be tough to find a pharmacy who has it in stock.

3. Contrave

Contrave is a potential oral Zepbound alternative. Contrave is a tablet that contains two medications: naltrexone and bupropion. These active ingredients work together to help lower your appetite and reduce food cravings. It may be helpful if you experience emotional eating.

After the first few weeks of taking Contrave, the standard dosage is 2 pills twice a day. In general, people typically lose less weight with oral weight-loss medications than injections, such as Zepbound. On average, people taking Contrave in studies lost between 5% and 8% of their starting body weight.

Contrave has different risks and side effects than Zepbound. For instance, both can cause stomach upset and diarrhea. But Contrave can also cause trouble sleeping and higher blood pressure. You may not be able to take Contrave if you have a history of seizures or an eating disorder. Contrave also has unique interactions to consider.

If you're changing from Zepbound to Contrave, it's a good idea to review your full medical history and medication list with your prescriber. They can use this information to let you know if you can safely make the switch.

Unlike the injectable medications we've discussed, there have been no reported shortages of Contrave at this time. It should be available at most pharmacies if you decide it's the right choice for you.

4. Qsymia

Qsymia (phentermine / topiramate ER) is another oral Zepbound alternative. Like Contrave, it's a combination pill. The two medications - phentermine and topiramate - work together to reduce your appetite.

Qsymia's typical dosage may be more convenient for some people than Contrave's. You typically take 1 pill once a day in the morning. As with other oral options, you may lose less weight with Qsymia than with Zepbound. Most people lost about 8% to 10% of their starting body weight while taking Qsymia in clinical trials.

You and your prescriber should discuss Qsymia's side effects, risks, and interactions before switching to it. This medication commonly causes numbness or tingling, constipation, and dry mouth.

Qsymia can also cause severe birth defects. Because of this, there's a mandatory risk management program for the medication. If you're able to get pregnant, you'll have to take a pregnancy test before starting Qsymia, and then subsequently once a month for as long as you're taking it. You'll also need to use an effective form of birth control while taking Qsymia.

There's no shortage of Qsymia right now. So it should be more readily available than Zepbound. But because of Qsymia's risk management program, pharmacies must be certified through the FDA to dispense it. So not all pharmacies may be able to fill a prescription for it.

5. Xenical

Another oral Zepbound alternative to consider is Xenical (orlistat). Its active ingredient is also available over the counter in lower doses under the brand name Alli.

Xenical works differently than the other Zepbound alternatives discussed above. It blocks your body from absorbing fat from the foods you eat. But in order for it to be effective, you need to take Xenical 3 times daily with meals that contain fat. On average, people lost about 8.5% of their starting body weight when taking Xenical in clinical trials.

Xenical can cause some uncomfortable side effects. These include loose or oily stools, stomach pain, and gas with oily spotting. It can also prevent your body from absorbing certain vitamins from your diet. It's common for prescribers to recommend taking a multivitamin if you're also taking Xenical.

Similar to the oral weight-loss medications listed above, there's no shortage of Xenical. So you may have an easier time getting a prescription for it filled.

When will the Zepbound shortage be resolved?

It's unclear when the Zepbound shortage will be resolved. Lilly (Zepbound's manufacturer) has been increasing their production of the medication over the past few months. They've also stated they'll continue to increase production as much as they can.

Keep in mind that only certain doses are impacted by the Zepbound shortage. The 10 mg and 15 mg doses are only available in limited supplies. But as of July 2024, the 2.5 mg, 5 mg, 7.5 mg, and 12.5 mg doses are currently listed as available.

Lilly recommends calling around to pharmacies in your area if your preferred pharmacy doesn't have your Zepbound dose in stock. They also suggest requesting your refills about 1 week ahead of time. This will give pharmacies extra time to order Zepbound for you.

The bottom line

Zepbound (tirzepatide) is a once-weekly weight-loss injection that's grown in popularity since its FDA approval. Because of this, certain doses are in short supply, leaving many people in need of alternatives.

Injectable Zepbound alternatives, such as Wegovy (semaglutide) and Saxenda (liraglutide), are the most similar options. But they're also impacted by drug shortages and may not be available. Oral Zepbound alternatives are more readily accessible but may not result in as much weight loss. These include Contrave (naltrexone / bupropion), Qsymia (phentermine / topiramate ER), and Xenical (orlistat).

Each Zepbound alternative has unique risks, side effects, and interactions. They also provide different amounts of weight loss. Discuss which option may be right for you with your prescriber.

View All References (16)
expand_more

ClinicalTrials.gov. (2024). A study of tirzepatide (LY3298176) on the reduction on morbidity and mortality in adults with obesity (SURMOUNT-MMO). U.S. National Library of Medicine.

Eli Lilly and Company. (2022). Zepbound- tirzepatide injection, solution [package insert].

FDA Drug Shortages. (2024). Liraglutide injection. U.S. Food and Drug Administration.

FDA Drug Shortages. (2024). Tirzepatide injection. U.S. Food and Drug Administration.

FDA Drug Shortages. (2024). Semaglutide injection. U.S. Food and Drug Administration.

Finer, N., et al. (2000). One-year treatment of obesity: A randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor. International Journal of Obesity.

Gadde, K. M., et al. (2011). Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): A randomised, placebo-controlled, phase 3 trial. The Lancet.

Haleon US Holdings LLC. (2024). Alli- orlistat capsule [package insert]. DailyMed.

H2-Pharma LLC. (1999). Xenical- orlistat capsule [package insert].

Jastreboff, A. M., et al. (2022). Tirzepatide once weekly for the treatment of obesity. The New England Journal of Medicine.

Lilly. (n.d.). What doses of Zepbound (tirzepatide) are available in the U.S.?

Lilly. (2024). Efforts to improve our Type 2 diabetes and obesity medicines supply: An update on the supply of Mounjaro (tirzepatide), Zepbound (tirzepatide) and Trulicity (dulaglutide).

Novo Nordisk Inc. (2017). Wegovy- semaglutide injection, solution [package insert].

Pi-Sunyer, X., et al. (2015). A randomized, controlled trial of 3.0 mg of liraglutide in weight management. The New England Journal of Medicine.

Sherman M. M., et al. (2016). Naltrexone / Bupropion ER (Contrave): Newly approved treatment option for chronic weight management in obese adults. Pharmacy and Therapeutics.

Vivus LLC. (2024). Risk of birth defects with Qsymia (phentermine and topiramate extended-release capsules).

GoodRx Health has strict sourcing policies and relies on primary sources such as medical organizations, governmental agencies, academic institutions, and peer-reviewed scientific journals. Learn more about how we ensure our content is accurate, thorough, and unbiased by reading our editorial guidelines.

Was this page helpful?

thumb_up_outlinedthumb_down_outlined
print_outlinedemail_outlined

Subscribe and save.

Get prescription saving tips and more from GoodRx Health. Enter your email to sign up.
Email address
Subscribe
I would also like to sign up for a free GoodRx account

By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.